These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 28374086)
1. Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway. Zhang J; Kuang Y; Wang Y; Xu Q; Ren Q Apoptosis; 2017 Jun; 22(6):877-884. PubMed ID: 28374086 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling. Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. Wang Z; Li Y; Banerjee S; Kong D; Ahmad A; Nogueira V; Hay N; Sarkar FH J Cell Biochem; 2010 Mar; 109(4):726-36. PubMed ID: 20052673 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration. Khusbu FY; Zhou X; Roy M; Chen FZ; Cao Q; Chen HC Int J Biochem Cell Biol; 2020 Jan; 118():105644. PubMed ID: 31712163 [TBL] [Abstract][Full Text] [Related]
6. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway. Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254 [TBL] [Abstract][Full Text] [Related]
7. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI). Sun Y; Jia X; Gao Q; Liu X; Hou L IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841 [TBL] [Abstract][Full Text] [Related]
8. Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells. Zhang L; Sha J; Yang G; Huang X; Bo J; Huang Y Cell Cycle; 2017 May; 16(10):999-1007. PubMed ID: 28388267 [TBL] [Abstract][Full Text] [Related]
9. Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling. Cheng C; Ji Z; Sheng Y; Wang J; Sun Y; Zhao H; Li X; Wang X; He Y; Yao J; Wang L; Zhang C; Guo Y; Zhang J; Gao WQ; Zhu HH Theranostics; 2018; 8(17):4633-4648. PubMed ID: 30279728 [TBL] [Abstract][Full Text] [Related]
10. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945 [TBL] [Abstract][Full Text] [Related]
11. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Hafeez BB; Siddiqui IA; Asim M; Malik A; Afaq F; Adhami VM; Saleem M; Din M; Mukhtar H Cancer Res; 2008 Oct; 68(20):8564-72. PubMed ID: 18922932 [TBL] [Abstract][Full Text] [Related]
12. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma. Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203 [TBL] [Abstract][Full Text] [Related]
13. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells. Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737 [TBL] [Abstract][Full Text] [Related]
14. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer. Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058 [TBL] [Abstract][Full Text] [Related]
15. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells. Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848 [TBL] [Abstract][Full Text] [Related]
18. ZNF692 promotes cell proliferation, invasion and migration of human prostate cancer cells by targeting the EMT signaling pathway. Chen H; Li Y; Wu G; Zeng Q; Huang H; Zhang G Eur J Med Res; 2024 Jan; 29(1):88. PubMed ID: 38291502 [TBL] [Abstract][Full Text] [Related]
19. Prostate cancer invasion is promoted by the miR-96-5p-induced NDRG1 deficiency through NF-κB regulation. Soror AA; Eshagh R; Fahim MR; Jamshidian A; Monfared GH Klin Onkol; 2024; 38(2):95-101. PubMed ID: 38697817 [TBL] [Abstract][Full Text] [Related]